Gemtuzumab ozogamicin (MylotargTM) is infrequently associated with sinusoidal obstructive syndrome/veno-occlusive disease

Efficacy and Safety of Gemtuzumab Ozogamicin in Patients With CD33-Positive Acute Myeloid Leukemia in First Relapse

2001 • 877 citations

Approval summary: gemtuzumab ozogamicin in relapsed acute myeloid leukemia.

2001 • 821 citations

Report of the National Cancer Institute-sponsored workshop on definitions of diagnosis and response in acute myeloid leukemia.

1990 • 813 citations

The syndrome of hepatic veno-occlusive disease after marrow transplantation

1995 • 475 citations

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

1999 • 458 citations

Selective Ablation of Acute Myeloid Leukemia Using Antibody-Targeted Chemotherapy: A Phase I Study of an Anti-CD33 Calicheamicin Immunoconjugate

1999 • 415 citations

Characterization of a reproducible rat model of hepatic veno-occlusive disease

1999 • 314 citations

HUMAN LIVER AFTER RADIATION INJURY. A FORM OF VENO-OCCLUSIVE DISEASE

1966 • 312 citations

Prior gemtuzumab ozogamicin exposure significantly increases the risk of veno-occlusive disease in patients who undergo myeloablative allogeneic stem cell transplantation

2003 • 304 citations

Mylotarg? (gemtuzumab ozogamicin) therapy is associated with hepatic venoocclusive disease in patients who have not received stem cell transplantation

2001 • 278 citations

Toxicity of azathioprine and monocrotaline in murine sinusoidal endothelial cells and hepatocytes: The role of glutathione and relevance to hepatic venoocclusive disease

1996 • 244 citations

Hepatic sinusoidal obstruction after gemtuzumab ozogamicin (Mylotarg) therapy

2002 • 240 citations

THE CLINICAL COURSE OF 53 PATIENTS WITH VENOCCLUSIVE DISEASE OF THE LIVER AFTER MARROW TRANSPLANTATION

1985 • 159 citations

Calicheamicin-DNA complexes: warhead alignment and saccharide recognition of the minor groove.

1995 • 92 citations

Gemtuzumab ozogamicin (Mylotarg) monotherapy for relapsed AML after hematopoietic stem cell transplant: efficacy and incidence of hepatic veno-occlusive disease

2002 • 76 citations

Hepatic veno-occlusive disease in two patients with relapsed acute myeloid leukemia treated with anti-CD33 calicheamicin (CMA-676) immunoconjugate

2001 • 52 citations

Molecular cloning of two isoforms of the murine homolog of the myeloid CD33 antigen

1994 • 51 citations

Management of Hepatic Sinusoidal Obstruction Syndrome Following Treatment with Gemtuzumab Ozogamicin (Mylotarg®)

2002 • 41 citations

Development of hepatic veno-occlusive disease after Mylotarg infusion for relapsed acute myeloid leukemia

2001 • 39 citations

Gemtuzumab ozogamicin

2001 • 37 citations